Miguel A Cruz Selected Research

Histones (Histone)

7/2013

Histone induced platelet aggregation is inhibited by normal albumin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel A Cruz Research Topics

Disease

14	Thrombosis (Thrombus) 06/2023 - 07/2009
8	Vascular System Injuries 01/2023 - 07/2002
6	Inflammation (Inflammations) 01/2023 - 07/2013
5	Sepsis (Septicemia) 06/2023 - 07/2013
5	Critical Illness (Critically Ill) 01/2023 - 05/2015
4	Hemorrhage 03/2022 - 06/2005
4	Thrombotic Thrombocytopenic Purpura 10/2015 - 06/2002
3	COVID-19 08/2022 - 01/2021
3	von Willebrand Diseases (von Willebrand's Disease) 01/2020 - 07/2009
3	Disseminated Intravascular Coagulation 01/2020 - 05/2015
3	Hemolysis 01/2018 - 11/2015
3	Thrombotic Microangiopathies 10/2015 - 01/2013
2	Infections 06/2023 - 02/2014
2	Endotoxemia 01/2020 - 05/2015
2	Type 2 von Willebrand Disease 01/2020 - 09/2008
2	Hemolytic-Uremic Syndrome 10/2015 - 11/2013
2	Thrombocytopenia (Thrombopenia) 10/2015 - 12/2003
2	platelet type Von Willebrand disease 06/2005 - 12/2003
1	Stroke (Strokes) 10/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2018
1	Ischemic Stroke 10/2018
1	Multiple Organ Failure (MODS) 10/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2014
1	ST Elevation Myocardial Infarction 11/2013
1	Diarrhea 11/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2013
1	Lymphoma (Lymphomas) 07/2013
1	Atypical Hemolytic Uremic Syndrome 01/2013
1	Rupture 01/2010
1	Sickle Cell Anemia (Hemoglobin S Disease) 06/2009
1	Neoplasms (Cancer) 10/2004
1	Hodgkin Disease (Hodgkin's Disease) 05/2004
1	Purpura 12/2003

Drug/Important Bio-Agent (IBA)

21	von Willebrand FactorIBA 01/2023 - 06/2002
6	FibrinIBA 01/2023 - 05/2015
6	Glycoproteins (Glycoprotein)IBA 01/2020 - 02/2007
4	Biomarkers (Surrogate Marker)IBA 06/2023 - 05/2004
3	Fibrinogen (Factor I)FDA Link 01/2023 - 12/2009
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2018
3	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 05/2015
2	VimentinIBA 01/2023 - 10/2018
2	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2022
2	CollagenIBA 08/2022 - 09/2015
2	Platelet Membrane GlycoproteinsIBA 01/2021 - 09/2008
2	Hemostatics (Antihemorrhagics)IBA 01/2020 - 11/2013
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 12/2015
2	thiamine triphosphorate (TTP)IBA 10/2015 - 12/2003
2	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 12/2011 - 07/2002
2	Metalloproteases (Metalloproteinases)IBA 12/2003 - 08/2003
1	AntibodiesIBA 01/2023
1	LigandsIBA 01/2023
1	AntigensIBA 08/2022
1	BuffersIBA 01/2022
1	P-SelectinIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	estropipate (Ogen)FDA LinkGeneric 01/2018
1	HaptoglobinsIBA 01/2018
1	HemopexinIBA 01/2018
1	IntegrinsIBA 12/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2016
1	Protein Kinases (Protein Kinase)IBA 12/2016
1	oxidized low density lipoproteinIBA 11/2013
1	N 30IBA 11/2013
1	Shiga Toxin (Shigella Toxin)IBA 11/2013
1	Histones (Histone)IBA 07/2013
1	ParaffinIBA 07/2013
1	MicroRNAs (MicroRNA)IBA 07/2013
1	Complement Factor H (Factor H)IBA 01/2013
1	Blood Proteins (Serum Proteins)IBA 01/2013
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 12/2009
1	Coloring Agents (Dyes)IBA 12/2009
1	Thrombin FDA Link 12/2009
1	Amino Acids FDA Link 06/2005
1	Messenger RNA (mRNA)IBA 10/2004
1	DisulfidesIBA 12/2003

Therapy/Procedure

4	Therapeutics 06/2023 - 05/2004
1	Heart-Assist Devices 03/2022
1	Extracorporeal Membrane Oxygenation 11/2015